Figure 3.
CVB inhibits the migration and invasion of ccRCC cells. (A, B) 786-O and ACHN cells were treated with CVB (0, 4, 8, and 16 μM) for 24 h and then subjected to wound healing assays. ***P < 0.01 vs. control group. (C, D) 786-O and ACHN cells were treated with CVB (0, 4, 8, and 16 μM) for 24 h, and the migratory and invasive abilities were assessed. ***P < 0.01 vs. control group.
